DJIA 17,172.68 -107.06 -0.62%
NASDAQ 4,527.69 -52.10 -1.14%
S&P 500 1,994.29 -16.11 -0.80%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)

2.75 -0.17 (-5.82%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ZIOP $2.75 -5.82%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.86
Previous Close $2.92
Daily Range $2.67 - $2.90
52-Week Range $2.67 - $5.58
Market Cap $277.0M
P/E Ratio -6.79
Dividend (Yield) $0.00 (0.0%)
Volume 969,787
Average Daily Volume 698,001
Current FY EPS -$0.40

Sector

Healthcare

Industry

Drugs

ZIOPHARM Oncology (ZIOP) Description

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. Website: http://www.ziopharm.com/

News & Commentary Rss Feed

This Week in Biotech: PTC Therapeutics Surprises, Isis' Data Dazzles, and Provectus Sinks

Four positive clinical updates, a billion-dollar licensing deal, a surprising positive opinion for one company in the EU, and a rough NYSEArca debut for one biopharma are this week's top biotech stories.

ZIOPHARM Oncology (ZIOP) in Focus: Stock Rises 10.4% - Tale of the Tape

Week In Review: PW Medtech Pays $130 Million For Fellow China Medical Device Company

Who Will Be Swimming Naked When The Tide Goes Out? (Part IV)

Ziopharm: Pipeline Expansion And Data Updates To Drive Near-Term Upside

Ziopharm Joins The CAR Crowd

ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And

ZIOPHARM Announces Expansion Of Ground-Breaking Synthetic Immuno-Oncology Programs With Intrexon And Clinical Program Update

Why Ziopharm Looks Worth Adding To Your Biotechnology Portfolio Pipeline

The Sirens Of Ziopharm

Can the Uptrend Continue for ZIOPHARM (ZIOP)? - Tale of the Tape

Mid-Morning Market Update: Markets Gain On Jobs Data; VeriFone Earnings Beat Estimates

See More ZIOP News...

ZIOP's Top Competitors

ZIOP $2.75 (-5.82%)
Current stock: ZIOP
AMGN $142.18 (-1.27%)
Current stock: AMGN
GILD $105.47 (-0.46%)
Current stock: GILD
BIIB $329.76 (0.16%)
Current stock: BIIB